DE602005023586D1 - Primer- und sondenkonstruktion zur effizienten amplifikation und detektion des 3'-nichttranslatierten bereichs von hcv - Google Patents

Primer- und sondenkonstruktion zur effizienten amplifikation und detektion des 3'-nichttranslatierten bereichs von hcv

Info

Publication number
DE602005023586D1
DE602005023586D1 DE602005023586T DE602005023586T DE602005023586D1 DE 602005023586 D1 DE602005023586 D1 DE 602005023586D1 DE 602005023586 T DE602005023586 T DE 602005023586T DE 602005023586 T DE602005023586 T DE 602005023586T DE 602005023586 D1 DE602005023586 D1 DE 602005023586D1
Authority
DE
Germany
Prior art keywords
nontranslated
hcv
primer
detection
field
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE602005023586T
Other languages
German (de)
English (en)
Inventor
Hwa-Tang Thomas Wang
Brian Washburn
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Biomerieux Inc
Original Assignee
Biomerieux Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biomerieux Inc filed Critical Biomerieux Inc
Publication of DE602005023586D1 publication Critical patent/DE602005023586D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701Specific hybridization probes
    • C12Q1/706Specific hybridization probes for hepatitis
    • C12Q1/707Specific hybridization probes for hepatitis non-A, non-B Hepatitis, excluding hepatitis D
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6806Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844Nucleic acid amplification reactions
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844Nucleic acid amplification reactions
    • C12Q1/6846Common amplification features
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844Nucleic acid amplification reactions
    • C12Q1/6851Quantitative amplification
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844Nucleic acid amplification reactions
    • C12Q1/686Polymerase chain reaction [PCR]

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Analytical Chemistry (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Analysing Materials By The Use Of Radiation (AREA)
DE602005023586T 2004-01-23 2005-01-21 Primer- und sondenkonstruktion zur effizienten amplifikation und detektion des 3'-nichttranslatierten bereichs von hcv Expired - Lifetime DE602005023586D1 (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US53881404P 2004-01-23 2004-01-23
US53881604P 2004-01-23 2004-01-23
US53881504P 2004-01-23 2004-01-23
PCT/US2005/002415 WO2005071117A2 (en) 2004-01-23 2005-01-21 Primer and probe design for efficient amplification and detection of hcv 3′ non-translating region

Publications (1)

Publication Number Publication Date
DE602005023586D1 true DE602005023586D1 (de) 2010-10-28

Family

ID=34812082

Family Applications (3)

Application Number Title Priority Date Filing Date
DE602005023586T Expired - Lifetime DE602005023586D1 (de) 2004-01-23 2005-01-21 Primer- und sondenkonstruktion zur effizienten amplifikation und detektion des 3'-nichttranslatierten bereichs von hcv
DE602005011754T Expired - Lifetime DE602005011754D1 (de) 2004-01-23 2005-01-21 Neuartiges nukleotidgemisch für ein verbessertes nukleinsäureamplifikationsverfahren
DE602005025424T Expired - Lifetime DE602005025424D1 (de) 2004-01-23 2005-01-21 Neuartiges Nukleotidgemisch für eine verbesserte Nukleinsäurenamplifikationsleistung

Family Applications After (2)

Application Number Title Priority Date Filing Date
DE602005011754T Expired - Lifetime DE602005011754D1 (de) 2004-01-23 2005-01-21 Neuartiges nukleotidgemisch für ein verbessertes nukleinsäureamplifikationsverfahren
DE602005025424T Expired - Lifetime DE602005025424D1 (de) 2004-01-23 2005-01-21 Neuartiges Nukleotidgemisch für eine verbesserte Nukleinsäurenamplifikationsleistung

Country Status (6)

Country Link
US (3) US7364854B2 (https=)
EP (3) EP2042612B1 (https=)
JP (2) JP2007518425A (https=)
AT (3) ATE491810T1 (https=)
DE (3) DE602005023586D1 (https=)
WO (2) WO2005070027A2 (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2147118A4 (en) * 2007-04-27 2010-09-01 Eragen Biosciences Inc MATERIALS AND METHOD FOR DETECTING HEPATITIS C VIRUS
US8435741B2 (en) 2007-07-26 2013-05-07 Fujifilm Corporation Isothermal nucleic acid amplification method using surfactant
US20090162856A1 (en) * 2007-11-06 2009-06-25 Hayato Miyoshi Rna detection method
RU2011132045A (ru) * 2008-12-31 2013-02-10 Эбботт Лэборетриз Праймеры и зонды для детектирования вируса гепатита с

Family Cites Families (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH09107970A (ja) * 1995-10-17 1997-04-28 Soyaku Gijutsu Kenkyusho:Kk C型肝炎ウイルス由来核酸、該核酸を用いたウイルスの検出方法
EP0052296B1 (en) * 1980-11-12 1984-06-27 Mitsubishi Kasei Corporation Glutamine derivatives usable for curing immune diseases, methods for their preparation and compositions comprising said derivatives
US5087565A (en) * 1984-07-02 1992-02-11 Du Pont Merck Pharmaceutical Company Synthetic process for preparation of 32 P-labeled nucleotides
DE3689223T2 (de) 1985-05-15 1994-03-03 Amoco Corp Cytidinanaloga.
US4876187A (en) 1985-12-05 1989-10-24 Meiogenics, Inc. Nucleic acid compositions with scissile linkage useful for detecting nucleic acid sequences
US5032511A (en) * 1987-03-31 1991-07-16 Mitsubishi Kasei Corporation DNA fragments coding for antigens specific to non-A non-B hepatitis, expression vectors containing said DNA fragments, transformants and process for producing said antigens
WO1989001050A1 (en) 1987-07-31 1989-02-09 The Board Of Trustees Of The Leland Stanford Junior University Selective amplification of target polynucleotide sequences
US5714596A (en) * 1987-11-18 1998-02-03 Chiron Corporation NANBV diagnostics: polynucleotides useful for screening for hepatitis C virus
US5712088A (en) * 1987-11-18 1998-01-27 Chiron Corporation Methods for detecting Hepatitis C virus using polynucleotides specific for same
US5698390A (en) * 1987-11-18 1997-12-16 Chiron Corporation Hepatitis C immunoassays
US5030557A (en) 1987-11-24 1991-07-09 Ml Technology Venture Means and method for enhancing nucleic acid hybridization
JP2650159B2 (ja) 1988-02-24 1997-09-03 アクゾ・ノベル・エヌ・ベー 核酸増幅方法
CA2020958C (en) 1989-07-11 2005-01-11 Daniel L. Kacian Nucleic acid sequence amplification methods
EP0578329B1 (en) 1989-09-18 1996-03-13 Canon Kabushiki Kaisha Ink jet recording head and ink jet apparatus having same
DK0515506T3 (da) * 1990-02-16 2000-05-08 Hoffmann La Roche Fremgangsmåde til påvisning af carcinogene humane papillomavirus
KR100249110B1 (ko) 1992-05-06 2000-04-01 다니엘 엘. 캐시앙 핵산 서열 증폭 방법, 이에 이용되는 조성물 및 키트
US5648232A (en) * 1993-01-21 1997-07-15 The Secretary Of State For Defence In Her Britannic Majesty's Government Of The United Kingdom Of Great Britain And Northern Ireland Microbiological best method and reagents
WO1995024499A1 (en) * 1994-03-10 1995-09-14 Gen-Probe Incorporated Method for suppressing inhibition of enzyme-mediated reactions by ionic detergents
US5874565A (en) * 1995-08-29 1999-02-23 Washington University Nucleic acids comprising a highly conserved novel 3 terminal sequence element of the hepatitis C virus
US6127116A (en) * 1995-08-29 2000-10-03 Washington University Functional DNA clone for hepatitis C virus (HCV) and uses thereof
DE19612779A1 (de) 1996-03-29 1997-10-02 Boehringer Mannheim Gmbh Verfahren zur spezifischen Vervielfältigung von langen Nukleinsäuren durch PCR
EP2264045B1 (en) * 1996-08-14 2015-10-21 Life Technologies Corporation Stable compositions for nucleic acid amplification and sequencing
DE19647055A1 (de) * 1996-11-14 1998-05-20 Boehringer Mannheim Gmbh Stabilisierte wässrige Nukleosidtriphosphat-Lösungen
EP0975806B1 (en) * 1997-04-03 2006-06-21 Invitrogen Corporation Compositions and methods for reverse transcriptase-polymerase chain reaction (rt-pcr)
ZA989950B (en) 1997-11-17 1999-05-04 Akzo Nobel Nv Transcription based amplification of double stranded DNA targets
JP2002512791A (ja) * 1998-04-27 2002-05-08 リボザイム・ファーマシューティカルズ・インコーポレーテッド C型肝炎ウイルス感染に関連する疾患または状態の酵素的核酸治療
AU4515699A (en) * 1998-06-26 2000-01-17 Akzo Nobel N.V. Tagging of rna amplicons generated by transcription-based amplification
US6638714B1 (en) * 1999-02-03 2003-10-28 Ortho-Clinical Diagnostics, Inc. Oligonucleotide primers for efficient detection of hepatitis C virus (HCV) and methods of use thereof
US6300075B1 (en) * 1999-02-03 2001-10-09 Ortho-Clinical Diagnostics, Inc Enhancement of the specificity of nucleic acid amplification by carrier nucleic acid
WO2000075338A2 (en) * 1999-06-04 2000-12-14 The Government Of The United States Of America As Represented By The Secretary, Department Of Health And Human Services CLONED GENONE OF INFECTIOUS HEPATITIS C VIRUS OF GENOTYPE 2a AND USES THEREOF
US6271004B1 (en) 1999-06-25 2001-08-07 Display Systems Biotech A/S Method for improved reverse transcription at high temperatures
EP1233976A4 (en) * 1999-11-17 2003-06-11 Jiuping Ji SIMULTANEOUS DETECTION OF HBV, HCV AND HIV IN PLASMA SAMPLES WITH THE AID OF A MULTIPLEX FIXING TEST
AU2001254670A1 (en) * 2000-03-02 2001-09-12 Akzo Nobel N.V. Detection of hepatitis b virus rna
EP1383782A1 (en) * 2001-03-26 2004-01-28 Sirna Therpeutics, Inc. Oligonucleotide mediated inhibition of hepatitis b virus and hepatitis c virus replication
WO2003016572A1 (en) * 2001-08-17 2003-02-27 Eli Lilly And Company Oligonucleotide therapeutics for treating hepatitis c virus infections
US6783940B2 (en) * 2001-10-31 2004-08-31 Applera Corporation Method of reducing non-specific amplification in PCR
US6750009B2 (en) * 2002-01-29 2004-06-15 Apath, Llc Multiple viral replicon culture systems
WO2003100014A2 (en) * 2002-05-24 2003-12-04 Smithkline Beecham Corporation Method for quantitating negative strand rna synthesis

Also Published As

Publication number Publication date
US20060019266A1 (en) 2006-01-26
US7670779B2 (en) 2010-03-02
EP1721015A2 (en) 2006-11-15
WO2005070027A2 (en) 2005-08-04
WO2005071117A2 (en) 2005-08-04
JP4866248B2 (ja) 2012-02-01
US7364854B2 (en) 2008-04-29
DE602005011754D1 (de) 2009-01-29
EP2042612A3 (en) 2009-06-17
EP1721015B1 (en) 2010-09-15
EP2042612B1 (en) 2010-12-15
ATE417938T1 (de) 2009-01-15
WO2005070027A3 (en) 2006-04-06
WO2005070027A8 (en) 2006-07-27
US20060003343A1 (en) 2006-01-05
JP2007518424A (ja) 2007-07-12
JP2007518425A (ja) 2007-07-12
US20080248480A1 (en) 2008-10-09
EP1706512B1 (en) 2008-12-17
EP2042612A2 (en) 2009-04-01
ATE491810T1 (de) 2011-01-15
ATE481507T1 (de) 2010-10-15
DE602005025424D1 (de) 2011-01-27
WO2005071117A3 (en) 2006-04-20
EP1706512A2 (en) 2006-10-04

Similar Documents

Publication Publication Date Title
DE60041940D1 (de) Oligonukleotidprimer zur effizienten Detektion von Hepatitis C Virus (HCV) sowie Verwendungsverfahren
ATE557083T1 (de) Thermostabiler oder thermoactiver dna-polymerase mit abgeschwächter 3'-5' exonukleaseaktivität
ATE394508T1 (de) Late-pcr
ATE454468T1 (de) Nachweis der instabilität von mikrosatelliten und verwendung davon bei der tumordiagnose
WO2006039537A8 (en) A system and method for inhibiting the decryption of a nucleic acid probe sequence used for the detection of a specific nucleic acid
ATE348881T1 (de) Thermostabiles taq polymerase fragment
DK1515752T3 (da) ACE2-aktivering til behandling af hjerte-, lunge- og nyresygdomme og hypertension
ATE534749T1 (de) Sonde und primer zum nachweis von tuberkelbazillen sowie verfahren zum nachweis von tuberkelbazillen beim menschen damit
ATE542917T1 (de) Zusammensetzungen, verfahren und kits zur bestimmung des vorhandenseins von trichomonas vaginalis in einer testprobe
DE60108337D1 (de) Methode und testsatz zur detektion von schistosomiasis mittels polymerasekettenreaktion
DE60132924D1 (de) Zusammensetzungen und methoden zur detektion von humanem immundefizienz virus 2 (hiv-2)
ATE546550T1 (de) Verfahren zum nachweis von hpv sowie sonden, primer und kits
ATE469162T1 (de) Verfahren und zusammensetzungen zur identifizierung und charakterisierung von hepatitis c
DE602005023586D1 (de) Primer- und sondenkonstruktion zur effizienten amplifikation und detektion des 3'-nichttranslatierten bereichs von hcv
ATE348170T1 (de) Verfahren zur detektion und quantifizierung von menschlichen p450-molekülen und sonde und kit für dieses verfahren
ATE484515T1 (de) Dna-polymerase-mischungen und mutante dna- polymerasen
Lee et al. Development of molecular diagnostic system with high sensitivity for the detection of human Sapovirus from water environments
ATE454476T1 (de) 3'-modifizierte oligonukleotide mit pseudoisocytosin-nukleobasenderivaten sowie deren anwendungen als primer oder sonden
DE602004028862D1 (de) Der nukleinsäuren von hiv-1 und hiv-2
TW200700557A (en) Rt-pcr detection for differential diagnosis field isolates or lapinized vaccine strain of classical swine fever virus (csfv) in samples
DE602004021094D1 (de) Gewinnung von dna
ATE486932T1 (de) Thermostabile dna polymerase von archae ampullavirus abv und dessen verwendungen
ATE331784T1 (de) Verfahren zur diagnose von fettsucht